Related content

Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease

By Järvelä I.  

Human Molecular Genetics, Vol. 7, Iss. 1, 1998-01 ,pp. : 85-90

Oxford University Press

Access to resources Recommend Favorite

CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease

By Lehtovirta M.   Luiro K.   Kopra O.   Jalanko A.  

Human Molecular Genetics, Vol. 10, Iss. 19, 2001-09 ,pp. : 2123-2131

Oxford University Press

Access to resources Recommend Favorite

The Batten disease gene product (CLN3p) is a Golgi integral membrane protein

By Chataway T.K.  

Human Molecular Genetics, Vol. 8, Iss. 3, 1999-03 ,pp. : 523-531

Oxford University Press

Access to resources Recommend Favorite

The Batten disease gene CLN3 is required for the response to oxidative stress

By Tuxworth Richard I.   Chen Haiyang   Vivancos Valerie   Carvajal Nancy   Huang Xun   Tear Guy  

Human Molecular Genetics, Vol. 20, Iss. 10, 2011-05 ,pp. : 2037-2047

Oxford University Press

Access to resources Recommend Favorite

Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)

By Järvelä Irma   Lehtovirta Maarit   Tikkanen Ritva   Kyttälä Aija   Jalanko Anu   Santavuori P.   Mitchison H.M.   Janes R.W.   Munroe P.B.   Lauronen L.   Järvelä I.   Wisniewski K.E.   Järvelä I.   Pearce D.A.   Pearce D.A.   Croopnick J.B.   Fearnley I.M.   Palmer D.N.   Katz M.L.   Zeman W.   Olkkonen V.M.   Williams M.A.   Harter C.   Johnson K.F.   Johnson K.F.   Letourneur F.   Goebel H.H.   Hohman T.C.   Ikonen E.   Riikonen A.   Kyttälä A.   Michalewski M.P.   Linial M.   Ferro-Novick S.   Nixon R.A.   Cameron P.L.   Sanger F.   Andersson S.   Luthman H.   Proia R.L.   Laemmli U.K.   Aniento F.   Tokuyasu K.T.   Slot J.W.   Pohlmann R.   Nakayama Y.  

Human Molecular Genetics, Vol. 8, Iss. 6, 1999-06 ,pp. : 1091-1098

Oxford University Press

Access to resources Recommend Favorite